Ipamorelin vs Ghrp 6
Which Is Right for You? Complete Comparison (2026)
Ipamorelin vs GHRP-6 comparison — selective GH release with minimal side effects vs strong appetite stimulation via ghrelin mimicry, dosing protocols.
Ipamorelin vs Ghrp 6: At a Glance
- ✓Selective growth hormone releasing peptide (GHRP)
- ✓Stimulates pituitary GH release via ghrelin/GHS-R1a receptor
- ✓Does not significantly elevate cortisol, prolactin, or aldosterone
- ✓Produces a clean GH pulse similar to natural secretion
- ✓Half-life approximately 2 hours — administered 2-3x daily
- ✓First-generation growth hormone releasing hexapeptide
- ✓Strong GH release via ghrelin receptor activation
- ✓Significantly increases appetite (hunger-promoting)
- ✓Raises cortisol and prolactin more than GHRP-2 or Ipamorelin
- ✓Half-life approximately 15-20 minutes
Detailed Comparison
| Feature | Ipamorelin | Ghrp 6 |
|---|---|---|
| Mechanism | Growth hormone secretagogue (selective GHRP) | Growth hormone releasing hexapeptideBest |
| Dosing | 200-300 mcg SC 2-3x daily | 100-300 mcg SC 2-3x daily |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Half-life | ~2 hours | ~15-20 minutes |
| FDA Status | Not FDA-approved — research peptide | Not FDA-approved — research peptide |
| Key Trial | Raun K et al. Eur J Endocrinol 1998 — demonstrated selective GH release | Bowers CY et al. Endocrinology 1984 — first synthetic GH secretagogue |
| Side Effects | Headache, flushing, dizziness, injection site irritation — generally well-tolerated | Strong appetite increase, cortisol/prolactin elevation, water retention |
Which Should You Choose?
Ipamorelin (growth hormone secretagogue (selective ghrp)) and GHRP-6 (growth hormone releasing hexapeptide) serve different clinical roles despite both being in the GH secretagogue space. Ipamorelin selective gh secretagogue that stimulates gh release from the pituitary via ghrelin receptor without significantly raising cortisol, prolactin, or aldosterone. GHRP-6 first-generation gh secretagogue that stimulates strong gh release but significantly increases appetite and cortisol/prolactin.
Whichever you choose, track your protocol in Shotlee to build clean data for dose optimization and outcomes comparison.
Making an Informed Choice Between Ipamorelin and Ghrp 6
Choosing between Ipamorelin and Ghrp 6 depends on multiple individual factors including your specific health goals, tolerance profile, insurance coverage, and prescriber recommendation. While clinical trial data provides population-level efficacy and safety comparisons, your personal response may differ based on genetics, baseline health, concurrent conditions, and lifestyle factors. Use this comparison as a starting framework and discuss the specifics with your healthcare provider.
Head-to-head clinical trial data between Ipamorelin and Ghrp 6 is the gold standard for comparison, but such direct comparisons are not always available for every pair of compounds. Where head-to-head data is lacking, cross-trial comparisons provide useful but imperfect approximations — differences in patient populations, trial design, and endpoint definitions mean that numbers from separate trials are not directly interchangeable. Keep this context in mind when evaluating the comparison data presented here.
Tracking your personal response data in Shotlee is particularly valuable when switching between medications or considering a change. By documenting your outcomes on your current protocol — including efficacy metrics, side effect profile, adherence rate, and quality of life measures — you create an objective baseline for comparison if you transition to the alternative compound. This data transforms a subjective switching decision into an evidence-based protocol optimization.
Ipamorelin vs Ghrp 6: Frequently Asked Questions
Ipamorelin is a growth hormone secretagogue (selective ghrp) while GHRP-6 is a growth hormone releasing hexapeptide. They differ in mechanism, dosing, and clinical evidence. Your choice should depend on your specific goals and medical history.
Switching should be done under medical supervision. Your prescriber can advise on transition protocols. Track both in Shotlee for comparison data.
Ipamorelin works as a growth hormone secretagogue (selective ghrp) (200-300 mcg SC 2-3x daily), while GHRP-6 is a growth hormone releasing hexapeptide (100-300 mcg SC 2-3x daily). They have different half-lives (~2 hours vs ~15-20 minutes), side effect profiles, and levels of clinical evidence.
Yes. Shotlee supports tracking any medication or peptide. You can compare your results across different protocols.
Neither is universally better — the right choice depends on your individual health profile, treatment goals, side effect tolerance, insurance coverage, and prescriber recommendation. Clinical trial data shows efficacy differences in specific populations, but personal response varies. Track your experience with either medication in Shotlee to generate objective comparison data with your healthcare provider.
Switching between these medications should be done under medical supervision. Your prescriber will consider factors including your current response, reason for switching, dose equivalence, and transition timing. Use Shotlee to document your outcomes on the current medication so you have a clear baseline for comparison after switching.
Track Ipamorelin or Ghrp 6 in Shotlee
Free dose tracking, side effect logging, and outcome comparison for any medication protocol.
📚References & sources
Latest on Ipamorelin
The Science Behind the Peptide Craze
Peptides are surging in popularity among influencers and biohackers for everything from injury recovery to youthful skin, but the science lags far behind the hype. With FDA bans on key ones like BPC-157 and potential changes ahead, here's what you need to know about their evidence, safety, and gray-market realities.
5 min read
Wellness Awaits RFK Jr.'s FDA Move on Peptides
Health Secretary RFK Jr. hinted at FDA easing restrictions on popular peptides like BPC-157 and ipamorelin during a Joe Rogan podcast. Wellness fans hope for access from ethical suppliers, but experts warn of black market dangers. Discover the regulatory shift's potential impact on peptide therapy.
5 min read
Inside the Grey Market Peptide Boom: 'I'm Not Comfortable with Myself'
Dale, a 38-year-old former army HGV driver, shed pounds on Mounjaro but turned to grey market peptides when prices soared. Inside Discord groups buzzing with rave reviews, he bought unlicensed BPC157 and CJC-1295 with Ipamorelin. This glimpse reveals the booming, risky world of grey market peptide sourcing for weight loss.
5 min read